DEA Releases 2024 Aggregate Production Quotas for Controlled Substances

 ADHD in the News 2024-01-04


The Department of Justice and Drug Enforcement Administration’s (DEA) final order for the 2024 aggregate production quotas (APQ) for controlled substances has been published in the Federal Register. Following the November 2023 notice regarding the proposed APQs, all interested persons were invited to submit comments and concerns regarding the production of schedule I and II substances and list I chemicals.

View Article: Psychiatry Advisor, January 3, 2024




Other Articles in this Edition

Navigating an ADHD Diagnosis in Your 50s or 60s

Young Adults, Adolescents Discontinue ADHD Medication More Than Children

DEA Releases 2024 Aggregate Production Quotas for Controlled Substances

Social jetlag is associated with worse cognitive performance in children with ADHD

CF care may be more poorer for children with mental health issues

New ultrasound technology shows promise for preventing brain damage in premature and sick infants

Patients With Narcolepsy Face a Dual Nightmare of Medication Shortages and Stigma

Maryland Court Adopts 2-Part Test to Determine Future Attorney’s Accommodation for State Bar Exam

Hidden panels, counterfeit bottles, fentanyl: A year of buying drugs in Mexican pharmacies

New $5 million NIH grant to study how pregnancy affects children with disabilities

Parenting with ADHD: 7 practical tips for success

The Connection Between Alexithymia and Severe ADHD

Is It Ok to Self-Diagnose a Mental Illness?